TABLE 2

Cross-species pharmacokinetics summary for 1 and total radioactivity after oral administration of [14C]1

1aTotal Radioactivity
RatMonkeyRatMonkey
Tmaxb2.1 ± 2.41.0 ± 0.04.8 ± 2.61.0 ± 0.0
Cmaxc116 ± 3796.2 ± 21.6183 ± 29580 ± 146
t1/2b9.8 ± 1.84.7 ± 0.918.9 ± 5.75.3 ± 1.0
AUC0–24d1609 ± 507726 ± 1953303 ± 3523188 ± 156
AUC0-∞d2042 ± 497769 ± 2045702 ± 9963359 ± 140
CL/Fe25.3 ± 5.133.8 ± 7.7N.A.N.A.
CLRef5.6 ± 1.21.1 ± 0.6N.A.N.A.
(CLR/fu)/GFRg2.2 ± 0.50.6 ± 0.3N.A.N.A.
  • N.A., not applicable.

  • a Oral doses of 3 and 1.5 mg/kg [14C]1 for rats and monkeys, respectively.

  • b Units are hours.

  • c Units are ng/ml and ng-Eq/ml for 1 and total radioactivity, respectively.

  • d Units are ng · h/ml and ng-Eq · h/ml for 1 and total radioactivity, respectively.

  • e Units are ml/min/kg.

  • f Calculated by Ae0-t/AUC0-∞ and animal weight-normalized; t = 72 and 48 h for rat and monkey, respectively.

  • g Unbound plasma fraction (fu) was 0.43 and 0.52 for rat and monkey, respectively. Glomerular filtration rate was assumed to be 1.31 ml/min in rats and 10.4 ml/min in monkeys (Davies and Morris, 1993) and animal weight-normalized.